RT Journal Article
SR Electronic
T1 Sodium valproate and clonazepam for epilepsy
JF Drug and Therapeutics Bulletin
JO Drug Ther Bull
FD BMJ Publishing Group Ltd
SP 97
OP 98
DO 10.1136/dtb.13.25.97
VO 13
IS 25
YR 1975
UL http://dtb.bmj.com/content/13/25/97.abstract
AB Sodium valproate (Epilim - Reckitt-Labaz) and clonazepam (Rivotril - Roche) are two anti-epileptic drugs recently promoted in this country. Sodium valproate has been used elsewhere in Europe for several years. So far they have been employed predominantly for patients whose epilepsy is not controlled with conventional drugs. Sodium valproate and clonazepam are chemically unrelated. Clonazepam is a benzodiazepine, while the structure of sodium valproate is novel for an anticonvulsant. Sodium valproate appears to raise the concentration in the brain of gamma-aminobutyric acid (GABA), a naturally occurring inhibitory transmitter.1